Mesalamine
NDC 50742-371, mesalamine, capsule, extended release, from Ingenus Pharmaceuticals, LLC.
- Product NDC
- 50742-371
- Status
- Listed
- Labeler
- Ingenus Pharmaceuticals, LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218410
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50742-371 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE.375 g/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50742-371-12 | 50742037112 | 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-371-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/58503afe-b8d4-4710-a194-e3acd64ecf1f
Use it
Look up 50742-371 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50742-371 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50742-371. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.